Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Cholecalciferol × 1 year × Clear all

Sponsor

Conditions

Vitamin D Deficiency 3 Prostatic Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Psoriasis 1 Osteoporosis Secondary 1 Osteoarthritis 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Colorectal Adenocarcinoma 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Bone Metabolism Biomarkers 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡